Customer Service
About Us
Quality Control
Privacy Policy

Search:

For:



Back to Pure NewsCaps Home 01/14/2003

What is Vinpocetine?

Vinpocetine is an alkaloid derived from the leaves of periwinkle (Vinca minor L) (1) that was first developed in Europe over 20 years ago (1). Helpful for cognitive support and for maintaining cerebrovascular health, one possible mechanism of vinpocetine involves an increase in cerebrovascular blood flow, thus allowing for better oxygen distribution to cells (2). Studies have suggested that vinpocetine blocks calcium-calmodulin dependent cyclic GMP phosphodiesterase, which could result in an increase of cyclic GMP within the smooth muscle (1,2). A higher level of cyclic GMP can promote healthy vascular flow (1,2). Furthermore, studies have reported that in addition to its neuroprotective feature (2), vinpocetine acts as an antioxidant and provides cellular protection (1). In a double-blind placebo controlled clinical trial, 84 elderly subjects were given vinpocetine or a placebo over a period of 90 days (3). Results indicated that those supplementing with vinpocetine scored better on all cognitive examinations (3).

Well tolerated, vinpocetine is absorbed in the small intestine and then processed in the liver (1). Once in systemic circulation, vinpocetine is absorbed by most tissues in the body and crosses the blood brain barrier. Absorption is much better when taken with food, usually around 60% versus just 7% when taken on an empty stomach (1). General dosing recommendations range from 5-10 mg 1-4 times daily (1,4). Vinpocetine may be contraindicated for those taking warfarin/coumadin or who have any type of bleeding disorder or low blood pressure. This product is not recommended for pregnant or lactating women.

Pure Encapsulations Cognitive Factors contains 80 mg of ginkgo biloba 50:1 extract combined with 20 mg vinpocetine per capsule for high potential cognitive support. Recommended dosage is 1-2 capsules per day, in divided doses, with meals.

References:
1.) PDR® for Nutritional Supplements™. Hendler and Rorvik. Medical Economics Company, Inc. Montrale, NJ 2001.
2.) Mechanism of action of vinpocetine. Kiss B, Karpati E. Acta Pharm Hung1996; 66(5):213-24.
3.) A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. Balestreri R, Fontana L, Astengo F. J Am Geriatr Soc 1987; 35(5): 425-30.
4.) www.supplementinfo.org

For educational purposes only. Consult your physician for any health problems.
*This is a statement of nutritional support. This statement has not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


home  |  disclaimer  |  privacy policy  |  contact us  |  about pure